.custom-subheader { font-family: Roboto, "Helvetica Neue", Helvetica, Arial, sans-serif; font-size: 17px; font-weight: 600; line-height: 1.5em; margin-top: 1.5em; margin-bottom: 1em; }
Skip to main content

The rockefeller university

News & HighlightsNews
Displaying 94 of 2939 articles.
Study pinpoints what causes relapse after cancer immunotherapy
In many cancer patients who have been treated with immunotherapy, the tumor comes back. New research identifies the cells responsible for thwarting the treatment and offers new insights into how they do it.
Gene-editing technique opens door for HIV vaccine
Researchers successfully modified immune cells to produce antibodies that fight HIV. This strategy could eventually be used to develop a vaccine against the virus, among other conditions.
New hope for treating a childhood brain cancer
Recent research has shown that a drug known as MI-2 can kill cells that cause a fatal brain cancer. But only now have scientists been able to explain how the compound works: by targeting cholesterol production in tumors.
Researchers discover a common link among diverse cancer types
Some cancers have been traced to changes in histones, proteins responsible for packaging DNA and regulating genes. Now, research from Rockefeller scientists shows that, among tumors, mutations to these proteins are a lot more common than previously suspected.
Scientists find new clues about how the body stores fat
Scientists discovered a protein that plays a crucial role in regulating fatty acids, the molecules that make up body fat. This research could lead to new options for treating people with diseases associated with fatty acid buildup.
Researchers discover a weakness in a rare cancer that could be exploited with drugs
Researchers have identified a rare type of cancer cell that cannot make cholesterol, a key nutrient. By targeting this deficiency, scientists may be able to develop new strategies for treating the disease.
Sohail Tavazoie promoted to professor
Sohail Tavazoie, a physician-scientist who studies the genes that regulate a tumor’s ability to metastasize, has been promoted to professor.
Scientists caution that a rare childhood liver cancer can spread to the brain
A new report details three cases of secondary brain tumors in people with fibrolamellar hepatocellular carcinoma. The researchers say imaging tests could improve treatment for patients whose cancer spreads to the brain from the liver.
In brief: New molecular insights on a rare immune disorder
After figuring out the functions of two proteins involved in the rare genetic condition ICF, scientists pieced together the molecular process that is altered in the disease.
New immunotherapy approach boosts body’s ability to destroy cancer cells
A new treatment may help cancer patients who don't respond to traditional immunotherapy. Findings from the first-ever clinical trial reveal that it is effective in activating immune cells that kill cancer cells.
View
View